Omega Therapeutics (OMGA) News Today $0.83 -0.18 (-17.85%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Omega Therapeutics price target lowered to $4 from $9 at Piper SandlerNovember 16 at 2:49 AM | markets.businessinsider.comPiper Sandler Remains a Buy on Omega Therapeutics (OMGA)November 16 at 2:49 AM | markets.businessinsider.comShares of Flagship-founded biotech fall as CEO departsNovember 15 at 4:45 PM | bizjournals.comOmega Therapeutics CEO Mahesh Karande to depart, Kaan Certel to succeedNovember 15 at 11:45 AM | markets.businessinsider.comOmega Therapeutics Restructures Leadership and Strategic FocusNovember 15 at 11:45 AM | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Lowered by Raymond JamesRaymond James downgraded Omega Therapeutics from an "outperform" rating to a "market perform" rating in a research note on Friday.November 15 at 9:32 AM | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $4.00 by Analysts at Piper SandlerPiper Sandler lowered their target price on Omega Therapeutics from $9.00 to $4.00 and set an "overweight" rating for the company in a research note on Friday.November 15 at 8:06 AM | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9% - Should You Sell?Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9% - Here's What HappenedNovember 8, 2024 | marketbeat.comOmega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific MeetingsOctober 15, 2024 | globenewswire.comOmega Therapeutics Appoints New DirectorOctober 6, 2024 | investing.comOmega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsSeptember 17, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Shares Up 0.8%Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8%September 10, 2024 | marketbeat.comOmega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchAugust 14, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) Decreased by AnalystOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Analysts at Wedbush decreased their Q3 2024 earnings estimates for shares of Omega Therapeutics in a report issued on Tuesday, August 6th. Wedbush analyst R. Driscoll now expects that the company will earn ($0.34) per share for the quarter, dAugust 9, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Quotes, Forecast and News SummaryAugust 8, 2024 | benzinga.comOmega Therapeutics (NASDAQ:OMGA) Releases Earnings Results, Beats Expectations By $0.06 EPSOmega Therapeutics (NASDAQ:OMGA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.30) earnings per share for the quarter, topping analysts' consensus estimates of ($0.36) by $0.06. Omega Therapeutics had a negative net margin of 1,868.35% and a negative return on equity of 136.04%. The firm had revenue of $2.13 million for the quarter, compared to the consensus estimate of $1.25 million.August 7, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by WedbushWedbush reiterated an "outperform" rating and set a $12.00 price objective on shares of Omega Therapeutics in a research note on Wednesday.August 7, 2024 | marketbeat.comOmega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressAugust 6, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Trading Up 4.3%Omega Therapeutics (NASDAQ:OMGA) Shares Up 4.3%July 24, 2024 | marketbeat.comOmega Therapeutics Announces Election of Richard N. Kender to Board of DirectorsJune 24, 2024 | globenewswire.comRaymond James Begins Coverage on Omega Therapeutics (NASDAQ:OMGA)Raymond James started coverage on Omega Therapeutics in a research report on Tuesday. They set an "outperform" rating and a $12.00 target price for the company.June 18, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Trading 14.5% Higher Omega Therapeutics (NASDAQ:OMGA) Trading 14.5% HigherJune 6, 2024 | marketbeat.comOmega Therapeutics To Participate In Two Upcoming Investor ConferencesMay 30, 2024 | globenewswire.comOmega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business OfficerMay 29, 2024 | globenewswire.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. Raised by HC Wainwright (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for Omega Therapeutics in a report released on Monday, May 13th. HC Wainwright analyst R. Burns now forecasts that the company will post earninMay 15, 2024 | marketbeat.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Expected to Post Q3 2025 Earnings of ($0.29) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Investment analysts at HC Wainwright issued their Q3 2025 earnings per share (EPS) estimates for Omega Therapeutics in a research note issued on Monday, May 13th. HC Wainwright analyst R. Burns forecasts that the company will post earnings peMay 14, 2024 | marketbeat.comBuy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial PerformanceMay 13, 2024 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and set a $12.00 price target on shares of Omega Therapeutics in a report on Monday.May 13, 2024 | marketbeat.comEquities Analysts Offer Predictions for Omega Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at Chardan Capital issued their FY2025 earnings per share estimates for shares of Omega Therapeutics in a research note issued on Tuesday, May 7th. Chardan Capital analyst K. Nakae anticipates that the company willMay 10, 2024 | marketbeat.comOmega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersMay 8, 2024 | globenewswire.comOmega Therapeutics (NASDAQ:OMGA) Receives "Buy" Rating from Chardan CapitalChardan Capital reiterated a "buy" rating and issued a $7.00 target price on shares of Omega Therapeutics in a research report on Tuesday.May 7, 2024 | marketbeat.com4 Analysts Have This To Say About Omega TherapeuticsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineMay 7, 2024 | finance.yahoo.comBuy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical TrialsMay 7, 2024 | markets.businessinsider.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | markets.businessinsider.comOmega Therapeutics (NASDAQ:OMGA) Rating Reiterated by WedbushWedbush reiterated an "outperform" rating and issued a $12.00 price objective on shares of Omega Therapeutics in a research report on Monday.May 6, 2024 | marketbeat.comOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024May 6, 2024 | investorplace.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | globenewswire.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Forecasted to Post Q1 2024 Earnings of ($0.38) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Analysts at HC Wainwright increased their Q1 2024 EPS estimates for Omega Therapeutics in a research report issued to clients and investors on Tuesday, April 30th. HC Wainwright analyst R. Burns now forecasts that the company will post earninMay 2, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and issued a $12.00 target price on shares of Omega Therapeutics in a research report on Tuesday.April 30, 2024 | marketbeat.comOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingApril 23, 2024 | globenewswire.comOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlApril 9, 2024 | globenewswire.comOmega Therapeutics, Inc. to Post FY2024 Earnings of ($1.31) Per Share, Chardan Capital Forecasts (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Research analysts at Chardan Capital upped their FY2024 EPS estimates for shares of Omega Therapeutics in a research note issued to investors on Monday, April 1st. Chardan Capital analyst K. Nakae now anticipates that the company will earn ($April 4, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Earns "Overweight" Rating from Piper SandlerPiper Sandler reissued an "overweight" rating and issued a $9.00 price objective (down from $10.00) on shares of Omega Therapeutics in a report on Wednesday.April 3, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $7.00Chardan Capital dropped their target price on shares of Omega Therapeutics from $12.00 to $7.00 and set a "buy" rating for the company in a research report on Monday.April 1, 2024 | marketbeat.comOmega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'March 31, 2024 | seekingalpha.comWe Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth CarefullyMarch 29, 2024 | finance.yahoo.comOMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023March 29, 2024 | investorplace.comOmega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateMarch 28, 2024 | globenewswire.comOMGA Apr 2024 12.500 callMarch 16, 2024 | finance.yahoo.com Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide OMGA Media Mentions By Week OMGA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMGA News Sentiment▼-0.120.55▲Average Medical News Sentiment OMGA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMGA Articles This Week▼101▲OMGA Articles Average Week Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Chimerix News Today Renalytix News Today Karyopharm Therapeutics News Today Inventiva News Today Compass Therapeutics News Today Atai Life Sciences News Today Inozyme Pharma News Today Opthea News Today Inhibrx News Today Eton Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMGA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
